IG-SRT is highly effective. Clinical studies and our own experience show cure rates on the order of 99.3% for basal cell carcinoma and squamous cell carcinoma. In fact, IG-SRT ranks among the most effective treatments available for these types of skin cancer. This means that out of 100 skin cancers treated, about 99 are completely cured by the therapy. Such a success rate is comparable to, if not even a touch higher than, the success rates of Mohs surgery in published data. So patients can be confident that choosing IG-SRT does not mean compromising on the likelihood of a cure – it’s extremely effective when the full course of therapy is completed. The combination of precise targeting and the ability to adjust treatment as needed contributes to these excellent outcomes.
Category:
IG-SRT



